leisure time -WSS

leisure time

author：explore 2025-09-30 17:27:37 - browse：62

Sen. Bernie Sanders, I-Vt., chairman of the Senate Health, Education, Labor, and Pensions Committee listens during a hearing on Capitol Hill in Washington – politics and policy coverage from STAT — Senate health committee Chair Bernie Sanders (I-Vt.) wants to reward new medicines with prize money. Jose Luis Magana/AP

WASHINGTON — Sen. Bernie Sanders (I-Vt.) will finally get a study of his proposal to do away with drug patents and other intellectual property protections in favor of rewarding inventions with prize money. Sanders has been pushing the prize approach since he was a House representative, many years ago.

The measure directing the National Academies of Sciences, Engineering and Medicine to study the idea was added to the Pandemic All-Hazards and Preparedness Act a day before Sander’s health committee passed the bill. Three Republicans voted against the overall bill, which renews several federal biodefense and pandemic-preparedness programs.

Though Democrats last year passed historic legislation to let Medicare negotiate drug prices and cap seniors’ annual out-of-pocket drug costs, Sanders is demanding more drug price controls. He is delaying President Biden’s pick for running the National Institutes of Health until the president releases a plan to control drug prices.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Medicare to cover more brain scans related to Alzheimer’s drugs

WSS

Dana Farber says 6 studies to be retracted and 31 corrected

To bolster infectious disease surveillance, genomics powerhouses team up

High breast density mammograms need follow

Prior authorization reform is both possible and imperative

Printout prescription drug information shouldn’t go digital

Inaction leaves children at risk from dangerous chemotherapy drug

focus

leisure time

leisure time

At least 13 dead in Texas as scorching temps continue

Better Therapeutics data on benefit with GLP

Medical leaders decry Supreme Court decision on affirmative action

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

As demand for Covid shots wanes, Moderna seeks its next success

Maisha Meds is a PBM, but don't call it that

Duchenne breakthrough therapy leaves behind pioneering families

Bernie Sanders bashes nonprofit hospitals over their tax breaks

The high cost of giving birth even with insurance

The inclusion problem at the heart of rehabilitation research

hotspot

Kidney disease boosts cardiac arrest risk for Hispanics, Latinos

Dana Farber says 6 studies to be retracted and 31 corrected

Future doctors need a strong humanities education

Readout LOUD podcast: Merger Mondays, Ozempic panic

Female surgeons have lower rates of long

Massive project maps cells in human brain in unprecedented detail

focus

focus

hotspot

knowledge